US3314941A
(en)
|
1964-06-23 |
1967-04-18 |
American Cyanamid Co |
Novel substituted pyridodiazepins
|
US3370372A
(en)
*
|
1966-08-22 |
1968-02-27 |
Vern C. Thompson |
Bolt assembly for firearms
|
ZA848968B
(en)
|
1983-11-18 |
1986-06-25 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US5756747A
(en)
|
1989-02-27 |
1998-05-26 |
Riker Laboratories, Inc. |
1H-imidazo 4,5-c!quinolin-4-amines
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
US5037986A
(en)
|
1989-03-23 |
1991-08-06 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
|
NZ232740A
(en)
|
1989-04-20 |
1992-06-25 |
Riker Laboratories Inc |
Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
ATE121088T1
(de)
|
1990-10-05 |
1995-04-15 |
Minnesota Mining & Mfg |
Verfahren zur herstellung von imidazo(4,5- c>chinolin-4-aminen.
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
JPH09500128A
(ja)
|
1993-07-15 |
1997-01-07 |
ミネソタ マイニング アンド マニュファクチャリング カンパニー |
イミダゾ〔4,5−c〕ピリジン−4−アミン
|
CA2560114A1
(en)
|
1994-07-15 |
1996-02-01 |
The University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
US5741908A
(en)
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
US5693811A
(en)
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
EP0882727B9
(en)
|
1996-07-03 |
2005-06-15 |
Sumitomo Pharmaceuticals Company, Limited |
Novel purine derivatives
|
US6387938B1
(en)
|
1996-07-05 |
2002-05-14 |
Mochida Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
JP4391592B2
(ja)
|
1996-10-25 |
2009-12-24 |
スリーエム カンパニー |
Th2介在性および関連疾患治療のための免疫応答修飾化合物
|
US5939090A
(en)
|
1996-12-03 |
1999-08-17 |
3M Innovative Properties Company |
Gel formulations for topical drug delivery
|
US6069149A
(en)
|
1997-01-09 |
2000-05-30 |
Terumo Kabushiki Kaisha |
Amide derivatives and intermediates for the synthesis thereof
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6426334B1
(en)
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
CA2301575C
(en)
|
1997-05-20 |
2003-12-23 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
ES2205573T3
(es)
|
1997-11-28 |
2004-05-01 |
Sumitomo Pharmaceuticals Company, Limited |
Nuevo compuestos heterociclicos.
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
CA2361936C
(en)
|
1999-01-08 |
2009-06-16 |
3M Innovative Properties Company |
Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
JP2000247884A
(ja)
|
1999-03-01 |
2000-09-12 |
Sumitomo Pharmaceut Co Ltd |
アラキドン酸誘発皮膚疾患治療剤
|
NZ515957A
(en)
|
1999-06-08 |
2003-08-29 |
Aventis Pasteur |
Immunostimulant oligonucleotide
|
US6541485B1
(en)
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6756382B2
(en)
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6451810B1
(en)
|
1999-06-10 |
2002-09-17 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6573273B1
(en)
|
1999-06-10 |
2003-06-03 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
AU783745B2
(en)
|
1999-08-13 |
2005-12-01 |
Hybridon, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
US6376669B1
(en)
|
1999-11-05 |
2002-04-23 |
3M Innovative Properties Company |
Dye labeled imidazoquinoline compounds
|
JP2003528068A
(ja)
|
2000-03-17 |
2003-09-24 |
コリクサ コーポレイション |
新規両親媒性アルデヒドならびにアジュバントおよび免疫エフェクターとしてのそれらの使用
|
US6894060B2
(en)
*
|
2000-03-30 |
2005-05-17 |
3M Innovative Properties Company |
Method for the treatment of dermal lesions caused by envenomation
|
US8119138B2
(en)
|
2000-05-10 |
2012-02-21 |
Signe Biopharma Inc. |
Anti-estrogen and immune modulator combinations for treating breast cancer
|
US6651132B1
(en)
|
2000-07-17 |
2003-11-18 |
Microsoft Corporation |
System and method for emulating the operation of a translation look-aside buffer
|
US20020055517A1
(en)
|
2000-09-15 |
2002-05-09 |
3M Innovative Properties Company |
Methods for delaying recurrence of herpes virus symptoms
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
CA2430206A1
(en)
|
2000-12-08 |
2002-06-13 |
3M Innovative Properties Company |
Screening method for identifying compounds that selectively induce interferon alpha
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US20030133913A1
(en)
|
2001-08-30 |
2003-07-17 |
3M Innovative Properties Company |
Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
|
JP4445262B2
(ja)
|
2001-10-09 |
2010-04-07 |
アムジェン インコーポレイテッド |
抗炎症剤としてのイミダゾール誘導体
|
JP2005519990A
(ja)
|
2001-10-12 |
2005-07-07 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
イミダゾキノリン化合物を用いて免疫応答を増強するための方法および産物
|
ES2318615T3
(es)
|
2001-11-16 |
2009-05-01 |
Coley Pharmaceutical Group, Inc. |
N-(4-(4-amino-2-etil-1h-imidazo(4,5-c)quinolin-1-il)butil)metanosulfonamida, una composicion farmaceutica que la comprende y uso de la misma.
|
YU45204A
(sh)
|
2001-11-27 |
2006-08-17 |
Anadys Pharmaceuticals Inc. |
3-BETA-D-RIBOFURANOZILTIAZOLO/4,5-d/ PIRIMIDINSKI NUKLEOZIDII NJIHOVA UPOTREBA
|
WO2004080430A2
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Methods of improving skin quality
|
DK1450804T3
(da)
|
2001-11-29 |
2009-01-05 |
3M Innovative Properties Co |
Farmaceutiske formulelringer, der omfatter et immunsvarmodificerende middel
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6525028B1
(en)
|
2002-02-04 |
2003-02-25 |
Corixa Corporation |
Immunoeffector compounds
|
SI1478327T1
(sl)
|
2002-02-22 |
2015-08-31 |
Meda Ab |
Metoda za zmanjšanje in zdravljenje imunosupresije, inducirane z UV-B
|
GB0211649D0
(en)
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
EP1511746A2
(en)
|
2002-05-29 |
2005-03-09 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
EP1513524A4
(en)
|
2002-06-07 |
2008-09-03 |
3M Innovative Properties Co |
WITH ETHER SUBSTITUTED IMIDAZOPYRIDINE
|
CA2493227A1
(en)
|
2002-07-23 |
2004-01-29 |
Biogal Gyogyszergyar Rt. |
Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via1h-imidazo [4,5-c]quinolin-4-phthalimide intermediates
|
AU2003254221A1
(en)
|
2002-07-26 |
2004-02-16 |
Biogal Gyogyszergyar Rt. |
Preparation of 1h-imidazo (4,5-c) quinolin-4-amines via novel 1h-imidazo (4,5-c) quinolin-4-cyano and 1h-imidazo (4,5-c) quinolin-4-carboxamide intermediates
|
DE60335010D1
(de)
|
2002-08-15 |
2010-12-30 |
3M Innovative Properties Co |
Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
|
US6818650B2
(en)
|
2002-09-26 |
2004-11-16 |
3M Innovative Properties Company |
1H-imidazo dimers
|
WO2004053057A2
(en)
|
2002-12-11 |
2004-06-24 |
3M Innovative Properties Company |
Gene expression systems and recombinant cell lines
|
WO2004053452A2
(en)
|
2002-12-11 |
2004-06-24 |
3M Innovative Properties Company |
Assays relating to toll-like receptor activity
|
AU2003301052A1
(en)
|
2002-12-20 |
2004-07-22 |
3M Innovative Properties Company |
Aryl / hetaryl substituted imidazoquinolines
|
WO2004060319A2
(en)
|
2002-12-30 |
2004-07-22 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
WO2004071459A2
(en)
|
2003-02-13 |
2004-08-26 |
3M Innovative Properties Company |
Methods and compositions related to irm compounds and toll-like receptor 8
|
EP1599726A4
(en)
|
2003-02-27 |
2009-07-22 |
3M Innovative Properties Co |
SELECTIVE MODULATION OF TLR-MEDIATED BIOLOGICAL ACTIVITY
|
US8110582B2
(en)
|
2003-03-04 |
2012-02-07 |
3M Innovative Properties Company |
Prophylactic treatment of UV-induced epidermal neoplasia
|
US7163947B2
(en)
|
2003-03-07 |
2007-01-16 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
TW200505458A
(en)
|
2003-03-07 |
2005-02-16 |
3M Innovative Properties Co |
1-amino 1h-imidazoquinolines
|
AU2004220465A1
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
WO2004080293A2
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Methods for diagnosing skin lesions
|
US20040191833A1
(en)
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Selective activation of cellular activities mediated through a common toll-like receptor
|
US20040192585A1
(en)
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
EP1617871A4
(en)
|
2003-04-10 |
2010-10-06 |
3M Innovative Properties Co |
DISTRIBUTION OF IMMUNE-RESPONSE-MODIFYING COMPOUNDS USING PARTICULATE CARRIER MATERIALS CONTAINING METAL
|
WO2004096144A2
(en)
|
2003-04-28 |
2004-11-11 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
KR20060016817A
(ko)
*
|
2003-06-20 |
2006-02-22 |
콜리 파마슈티칼 게엠베하 |
소분자 톨-유사 수용체 (tlr) 길항제
|
EP1653914A4
(en)
|
2003-08-12 |
2008-10-29 |
3M Innovative Properties Co |
COMPOUNDS CONTAINING OXIME SUBSTITUTED IMIDAZO STRUCTURE
|
US7193656B2
(en)
|
2003-08-14 |
2007-03-20 |
Broadcom Corporation |
Line address computer for providing coefficients to a chroma filter
|
US7897597B2
(en)
|
2003-08-27 |
2011-03-01 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted imidazoquinolines
|
EP1667694B1
(en)
|
2003-09-05 |
2010-04-28 |
Anadys Pharmaceuticals, Inc. |
Tlr7 ligands for the treatment of hepatitis c
|
CA2536530A1
(en)
|
2003-10-01 |
2005-04-14 |
Taro Pharmaceuticals U.S.A., Inc. |
Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
|
BRPI0414856A
(pt)
|
2003-10-03 |
2006-11-21 |
3M Innovative Properties Co |
imidazoquinolinas alcóxi-substituìdas
|
KR20060120069A
(ko)
|
2003-10-03 |
2006-11-24 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
피라졸로피리딘 및 그의 유사체
|
ITMI20032121A1
(it)
|
2003-11-04 |
2005-05-05 |
Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm |
Procedimento per la preparazione di imiquimod e suoi intermedi
|
AU2004291101A1
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Oxime substituted imidazo ring compounds
|
EP1682544A4
(en)
|
2003-11-14 |
2009-05-06 |
3M Innovative Properties Co |
HYDROXYLAMINE SUBSTITUTED IMIDAZO RING COMPOUNDS
|
US8778963B2
(en)
|
2003-11-25 |
2014-07-15 |
3M Innovative Properties Company |
Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
BRPI0416936A
(pt)
|
2003-11-25 |
2007-01-16 |
3M Innovative Properties Co |
sistemas de anel de imidazo substituìdos e métodos
|
TW200533352A
(en)
|
2003-12-04 |
2005-10-16 |
3M Innovative Properties Co |
Sulfone substituted imidazo ring ethers
|
EP1699792A1
(en)
|
2003-12-29 |
2006-09-13 |
3M Innovative Properties Company |
Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds
|
US8802853B2
(en)
|
2003-12-29 |
2014-08-12 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
AU2004312508A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
AU2005222995B2
(en)
|
2004-03-15 |
2010-08-26 |
3M Innovative Properties Company |
Immune response modifier formulations and methods
|
US20060062755A1
(en)
|
2004-09-21 |
2006-03-23 |
Woodward John R |
Method of cancer screening; method of cancer treatment; and method of diabetes treatment
|
EP1813855A1
(en)
*
|
2006-01-27 |
2007-08-01 |
L'AIR LIQUIDE, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude |
Process and arrangement for filling a high pressure gas container with liquefied gas under hydrostatic pressure
|